Niosome Encapsulated of Vincristine Sulfate: Improved Anticancer Activity with Reduced Toxicity in Mice
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 2 (2), 173-182
- https://doi.org/10.3109/10611869409015907
Abstract
Nonionic surfactant vesicles (niosomes) are promising drug carriers for anticancer drugs. Niosome encapsulated vincristine sulfate prepared by transmembrane pH gradient drug uptake process (remote loading method) was evaluated for toxicity and antitumour activity after administration to tumour bearing mice. The toxicity of vincristine sulfate was reduced after niosome encapsulation and anticancer activity improved, which may be due to better delivery of vincristine at the tumour site.Keywords
This publication has 5 references indexed in Scilit:
- Pharmacokinetic evaluation of surfactant vesicle-entrapped methotrexate in tumor-bearing miceInternational Journal of Pharmaceutics, 1990
- Mouse Bone-marrow Response to Low Doses of Whole-body Gamma Irradiation: Induction of MicronucleiInternational Journal of Radiation Biology, 1990
- Vesicles of variable sizes produced by a rapid extrusion procedureBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- The preparation and properties of niosomes—non-ionic surfactant vesiclesJournal of Pharmacy and Pharmacology, 1985
- The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in miceJournal of Pharmacy and Pharmacology, 1985